Ilomastat (Compound)

Synonyms:Ilomastat, Galardin, 142880-36-2, GM6001, GM 6001, Illomastat, CS 610, GM-6001, Ilomastat (GM6001, Galardin), (R)-N1-((S)-3-(1H-indol-3-yl)-1-(methylamino)-1-oxopropan-2-yl)-N4-hydroxy-2-isobutylsuccinamide, CHEMBL19611, DTXSID0046353, (R)-N(sup 1)-Hydroxy-N-((S)-2-indol-3-yl-1-(methylcarbamoyl)ethyl)-2-isobutylsuccinamide, I0403ML141, (S-(R*,S*))-N(sup 4)-Hydroxy-N(sup 1)-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxoethyl)-2-(2-methylopropyl)butanediamide, Ilomastat [USAN], NCGC00163450-02, 3-(N-HYDROXYCARBOXAMIDO)-2-ISOBUTYLPROPANOYL-TRP-METHYLAMIDE, CS-610, Galardin MPI, (2R)-N'-hydroxy-N-[(2S)-3-(1H-indol-3-yl)-1-(methylamino)-1-oxopropan-2-yl]-2-(2-methylpropyl)butanediamide, Ilomastat (USAN/INN), Ilomastat [USAN:INN], UNII-I0403ML141, 4pkw, GM6, MFCD03453614, ILOMASTAT [INN], ILOMASTAT [INCI], Ilomastat; GM-6001, (R)-N4-Hydroxy-N1-[(S)-2-(1H-indol-3-yl)-1-methylcarbamoyl-ethyl]-2-isobutyl-succinamide, GM6001;Galardin;Ilomastat, CBiol_001883, SCHEMBL35303, BSPBio_001079, KBioGR_000419, KBioSS_000419, GTPL7409, DTXCID8026353, BCBcMAP01_000057, KBio2_000419, KBio2_002987, KBio2_005555, KBio3_000797, KBio3_000798, EX-A765, CHEBI:137236, BDBM234334, Bio1_000169, Bio1_000658, Bio1_001147, Bio2_000370, Bio2_000850, HMS1362E21, HMS1792E21, HMS1990E21, HMS3403E21, Tox21_112055, BDBM50062351, NSC727632, s7157, AKOS016355429, CCG-207857, CS-1701, DB02255, NSC-727632, IDI1_002125, SMP2_000212, NCGC00163450-01, NCGC00163450-03, NCGC00163450-04, AS-56152, Butanediamide, N4-hydroxy-N1-((1S)-1-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxoethyl)-2-(2-methylpropyl)-, (2R)-, Butanediamide, N4-hydroxy-N1-(1-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxoethyl)-2-(2-methylpropyl)-, (S-(R*,S*))-, HY-15768, CAS-142880-36-2, SW218170-2, D03793, J-007712, BRD-K51662849-001-02-1, GM 6001 - CAS 142880-36-2, (R)-N*4*-Hydroxy-N*1*-[2-(1H-indol-3-yl)-1-methylcarbamoyl-ethyl]-2-isobutyl-succinamide, (2R)-N'-hydroxy-N-[(2S)-3-(1H-indol-3-yl)-1-methylamino-1-oxopropan-2-yl]-2-(2-methylpropyl)butanediamide, (2R)-N(4)-hydroxy-N(1)-[(2S)-3-(1H-indol-3-yl)-1-(methylamino)-1-oxopropan-2-yl]-2-(2-methylpropyl)butanediamide, (2R)-N4-Hydroxy-N1-[(1S)-1-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxoethyl]-2-(2-methylpropyl)butanediamide, (R)-N*4*-Hydroxy-N*1*-[(S)-2-(1H-indol-3-yl)-1-methylcarbamoyl-ethyl]-2-isobutyl-succinamide, (R)-N1-((S)-3-(1H-Indol-3-yl)-1-(methylamino)-1-oxopropan-2-yl)-N4-hydroxy-2-isobutyl succinamide
Id:132519
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Ilomastat's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Ilomastat.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Ilomastat.

This repository is under review for potential modification in compliance with Administration directives.